Closed Restricted Access Barrier System – cRABS

What is the Closed Restricted Access Barrier System ?

The Closed Restricted Access Barrier System (cRABS) designed by Shanghai QUALIA is a state-of-the-art aseptic processing solution that creates a highly controlled, enclosed environment to protect sterile or minimally toxic product production. The system maintains a positive pressure regime, employing advanced air filtration systems that deliver air cleanliness at high levels, in accordance with air quality standards. The integrity of the sterile environment is preserved by keeping the system’s doors sealed during operation.

Features of Shanghai QUALIA's Closed Restricted Access Barrier System (cRABS)

  • Air Filtration: HEPA filters installed in QUALIA’s cRABS ensure maintenance of ISO Class 5 air purity. The airflow is expertly engineered to prevent contamination and sustain a pristine environment within the system.
  • Physical Barrier: A solid barrier prevents direct operator-product contact, safeguarding product sterility.
  • Controlled Environment: All critical environmental parameters, such as temperature, humidity, and pressure, are meticulously managed to suit sensitive pharmaceutical handling.
  • Design Versatility: The systems are inherently versatile, designed to be adapted to varied production needs and facility configurations. They can include features like integrated glove ports, state-of-the-art LED illumination, and comprehensive control systems for precise monitoring and automation.

Different Types of Closed Restricted Access Barrier System (cRABS)

Shanghai QUALIA’s cRABS is available in multiple configurations to cater to diverse operation requirements, including:

  • Passive cRABS: These utilize the facility’s existing HVAC airflow, leveraging centrally supplied HEPA-filtered air for maintaining a clean atmosphere.
  • Active cRABS: Featuring an autonomous air handling unit, this variant enables complete environmental control and may include advanced options for automated decontamination and specialized material transfer systems.

 

Picture of Barry Liu

Barry Liu

Hi, I’m Barry Liu, a Sales Engineer at QUALIA. I’ve worked with laboratory biosafety equipment since 2010 and have conducted more than 200 on-site biosafety cabinet certifications. I write about evaluating containment filtration, vaporized hydrogen peroxide (VHP) generators and cycle validation, and effluent decontamination systems.

Related News

How to Configure a VHP Cycle in an Isolator for Sterility and Material Safety

Configuring a VHP cycle in an isolator requires balancing the sterility assurance level against material compatibility, because the enclosed environment concentrates H2O2 vapour and accelerates oxidative stress on components. This article covers cycle parameter selection, material risk assessment, and validation approaches for isolator VHP cycles.

Unlocking Innovation in Biotechnology: A Glimpse into QUALIA’s Project Portfolio

In the ever-evolving landscape of biotechnology, innovation is the lifeblood that drives progress and saves lives. At the forefront of this revolution is QUALIA, a company that has been instrumental in fostering groundbreaking advancements in the bio-pharmaceutical and biotechnological sectors. Let's delve into some of the remarkable projects and partners that make up QUALIA's impressive portfolio. Pioneering Vaccine Development: Shenlian Bio Imagine a world where diseases like foot-and-mouth disease are a thing of the past. Shenlian Bio, a key partner of QUALIA, has made this vision a reality by developing the world's first synthetic peptide vaccine against foot-and-mouth disease. This breakthrough has significantly contributed to disease prevention in China and underscores the company's commitment to cutting-edge technology and public health. Comprehensive Pharmaceutical Services: Pharmaron Pharmaron,

Scroll to Top

Contact Us Now

Contact us directly: [email protected]